Molecular Metabolism (Mar 2016)

Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients

  • Henriette Kirchner,
  • Indranil Sinha,
  • Hui Gao,
  • Maxwell A. Ruby,
  • Milena Schönke,
  • Jessica M. Lindvall,
  • Romain Barrès,
  • Anna Krook,
  • Erik Näslund,
  • Karin Dahlman-Wright,
  • Juleen R. Zierath

Journal volume & issue
Vol. 5, no. 3
pp. 171 – 183

Abstract

Read online

Objective: Epigenetic modifications contribute to the etiology of type 2 diabetes. Method: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insulin resistance. Results were validated by pyrosequencing. Result: We identified hypomethylation of genes involved in hepatic glycolysis and insulin resistance, concomitant with increased mRNA expression and protein levels. Pyrosequencing revealed the CpG-site within ATF-motifs was hypomethylated in four of these genes in liver of severely obese non-diabetic and type 2 diabetic patients, suggesting epigenetic regulation of transcription by altered ATF-DNA binding. Conclusion: Severely obese non-diabetic and type 2 diabetic patients have distinct alterations in the hepatic methylome and transcriptome, with hypomethylation of several genes controlling glucose metabolism within the ATF-motif regulatory site. Obesity appears to shift the epigenetic program of the liver towards increased glycolysis and lipogenesis, which may exacerbate the development of insulin resistance. Keywords: Liver, Obesity, Type 2 Diabetes, Epigenetics, Lipid, Glucose